Search

Your search keyword '"Welsh, Sarah"' showing total 553 results

Search Constraints

Start Over You searched for: Author "Welsh, Sarah" Remove constraint Author: "Welsh, Sarah"
553 results on '"Welsh, Sarah"'

Search Results

6. Oral Hypoxia-Inducible Factor 2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study

10. A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)

12. Oral HIF-2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study

13. K-means clustering of hyperpolarised 13C-MRI identifies intratumoural perfusion/metabolism mismatch in renal cell carcinoma as best predictor of highest grade

14. Probing intratumoral metabolic compartmentalisation in fumarate hydratase-deficient renal cancer using clinical hyperpolarised 13C-MRI and mass spectrometry imaging

16. Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer

21. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

27. The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol

28. Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disorders

31. Common methodological pitfalls in ICI pneumonitis risk prediction studies

32. Abstract A015: Injury-associated transcriptional state transitions in early renal carcinogenesis

33. Abstract PR002: Injury-associated transcriptional state transitions in early renal carcinogenesis

35. Educating Students about the Risks of Excessive Videogame Usage.

37. External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma

40. Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases

41. Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors

45. ‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors

47. Supplementary Figure from A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma

48. Supplementary Table from A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma

49. Supplementary Data from A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma

50. Dynamic biomarker and imaging changes from a phase II study of pre- and post-surgical sunitinib

Catalog

Books, media, physical & digital resources